Vinblastine Sulfate

硫酸长春碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVinblastine Sulfate
Drug Alias NameVinblastina威保啶Vinblastinum酒石酸长春质碱Velbe +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin polymerisation inhibitors
TargetsTubulin
Therapy Area/IndicationsHodgkin DiseaseLymphoma
Global Approved IndicationsHodgkin DiseaseLymphoma
Approved Indications in ChinaHodgkin DiseaseLymphoma
Original Approved Country/TerritoryN/A
Original Approved Date1961/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHodgkin DiseaseLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01CA01